Sinus augmentation using a histone deacetylase inhibitor in a calcium sulfate carrier in rabbit: A pilot study

Jae Kook Cha, Hyun Chang Lim, Jung Seok Lee, Seong Ho Choi, Kyung Mi Woo, Ui Won Jung

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Histone deacetylase inhibitors such as sodium butyrate (SB) have been suggested to be promising candidate small molecules for bone regeneration. In this study, the capacity of SB loaded onto calcium sulfate (CaS) to enhance bone formation was investigated in a rabbit sinus model. Following preparation of the sinus access window on a randomly selected side, SB loaded onto CaS (CaS/SB) was grafted in five rabbits, and CaS alone (control) was grafted in another five rabbits. The animals were euthanized after 4 weeks for radiographic, histometric, and immunohistochemical analyses. There was a statistically significant difference in the total augmented volume between the groups in the radiographic analysis (158.22 ± 39.31 mm3 and 107.09 ± 39.69 mm3, respectively, p = 0.040). The CaS/SB group showed a larger portion of mature lamellar bone and a higher level of mineralization of bone trabeculae, characterized by more intense labeling with osteocalcin compared with the control group in the immunohistochemical analysis. The number of osteocalcin-positive cells within the central area of the augmented sinus was significantly higher in the CaS/SB group than in the control group (179 ± 26.0 mm2 and 123 ± 33.2 mm2, respectively, p = 0.027). In conclusion, CaS/SB exhibited superior osteogenic potential, especially in the central portion of the augmented sinus as well as improvement of the volume maintenance for sinus augmentation.

Original languageEnglish
Pages (from-to)1916-1923
Number of pages8
JournalJournal of Biomedical Materials Research - Part B Applied Biomaterials
Volume105
Issue number7
DOIs
Publication statusPublished - 2017 Oct

Fingerprint

Calcium Sulfate
Histone Deacetylase Inhibitors
Butyric Acid
Calcium
Sodium sulfate
Bone
Osteocalcin
Sodium
Sulfates
Histone Deacetylases
Labeling
Animals
Cells
Molecules

All Science Journal Classification (ASJC) codes

  • Biomaterials
  • Biomedical Engineering

Cite this

@article{74526655fffd4d1ebd01e00d8394e3bf,
title = "Sinus augmentation using a histone deacetylase inhibitor in a calcium sulfate carrier in rabbit: A pilot study",
abstract = "Histone deacetylase inhibitors such as sodium butyrate (SB) have been suggested to be promising candidate small molecules for bone regeneration. In this study, the capacity of SB loaded onto calcium sulfate (CaS) to enhance bone formation was investigated in a rabbit sinus model. Following preparation of the sinus access window on a randomly selected side, SB loaded onto CaS (CaS/SB) was grafted in five rabbits, and CaS alone (control) was grafted in another five rabbits. The animals were euthanized after 4 weeks for radiographic, histometric, and immunohistochemical analyses. There was a statistically significant difference in the total augmented volume between the groups in the radiographic analysis (158.22 ± 39.31 mm3 and 107.09 ± 39.69 mm3, respectively, p = 0.040). The CaS/SB group showed a larger portion of mature lamellar bone and a higher level of mineralization of bone trabeculae, characterized by more intense labeling with osteocalcin compared with the control group in the immunohistochemical analysis. The number of osteocalcin-positive cells within the central area of the augmented sinus was significantly higher in the CaS/SB group than in the control group (179 ± 26.0 mm2 and 123 ± 33.2 mm2, respectively, p = 0.027). In conclusion, CaS/SB exhibited superior osteogenic potential, especially in the central portion of the augmented sinus as well as improvement of the volume maintenance for sinus augmentation.",
author = "Cha, {Jae Kook} and Lim, {Hyun Chang} and Lee, {Jung Seok} and Choi, {Seong Ho} and Woo, {Kyung Mi} and Jung, {Ui Won}",
year = "2017",
month = "10",
doi = "10.1002/jbm.b.33727",
language = "English",
volume = "105",
pages = "1916--1923",
journal = "Journal of Biomedical Materials Research - Part B Applied Biomaterials",
issn = "1552-4973",
number = "7",

}

Sinus augmentation using a histone deacetylase inhibitor in a calcium sulfate carrier in rabbit : A pilot study. / Cha, Jae Kook; Lim, Hyun Chang; Lee, Jung Seok; Choi, Seong Ho; Woo, Kyung Mi; Jung, Ui Won.

In: Journal of Biomedical Materials Research - Part B Applied Biomaterials, Vol. 105, No. 7, 10.2017, p. 1916-1923.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Sinus augmentation using a histone deacetylase inhibitor in a calcium sulfate carrier in rabbit

T2 - A pilot study

AU - Cha, Jae Kook

AU - Lim, Hyun Chang

AU - Lee, Jung Seok

AU - Choi, Seong Ho

AU - Woo, Kyung Mi

AU - Jung, Ui Won

PY - 2017/10

Y1 - 2017/10

N2 - Histone deacetylase inhibitors such as sodium butyrate (SB) have been suggested to be promising candidate small molecules for bone regeneration. In this study, the capacity of SB loaded onto calcium sulfate (CaS) to enhance bone formation was investigated in a rabbit sinus model. Following preparation of the sinus access window on a randomly selected side, SB loaded onto CaS (CaS/SB) was grafted in five rabbits, and CaS alone (control) was grafted in another five rabbits. The animals were euthanized after 4 weeks for radiographic, histometric, and immunohistochemical analyses. There was a statistically significant difference in the total augmented volume between the groups in the radiographic analysis (158.22 ± 39.31 mm3 and 107.09 ± 39.69 mm3, respectively, p = 0.040). The CaS/SB group showed a larger portion of mature lamellar bone and a higher level of mineralization of bone trabeculae, characterized by more intense labeling with osteocalcin compared with the control group in the immunohistochemical analysis. The number of osteocalcin-positive cells within the central area of the augmented sinus was significantly higher in the CaS/SB group than in the control group (179 ± 26.0 mm2 and 123 ± 33.2 mm2, respectively, p = 0.027). In conclusion, CaS/SB exhibited superior osteogenic potential, especially in the central portion of the augmented sinus as well as improvement of the volume maintenance for sinus augmentation.

AB - Histone deacetylase inhibitors such as sodium butyrate (SB) have been suggested to be promising candidate small molecules for bone regeneration. In this study, the capacity of SB loaded onto calcium sulfate (CaS) to enhance bone formation was investigated in a rabbit sinus model. Following preparation of the sinus access window on a randomly selected side, SB loaded onto CaS (CaS/SB) was grafted in five rabbits, and CaS alone (control) was grafted in another five rabbits. The animals were euthanized after 4 weeks for radiographic, histometric, and immunohistochemical analyses. There was a statistically significant difference in the total augmented volume between the groups in the radiographic analysis (158.22 ± 39.31 mm3 and 107.09 ± 39.69 mm3, respectively, p = 0.040). The CaS/SB group showed a larger portion of mature lamellar bone and a higher level of mineralization of bone trabeculae, characterized by more intense labeling with osteocalcin compared with the control group in the immunohistochemical analysis. The number of osteocalcin-positive cells within the central area of the augmented sinus was significantly higher in the CaS/SB group than in the control group (179 ± 26.0 mm2 and 123 ± 33.2 mm2, respectively, p = 0.027). In conclusion, CaS/SB exhibited superior osteogenic potential, especially in the central portion of the augmented sinus as well as improvement of the volume maintenance for sinus augmentation.

UR - http://www.scopus.com/inward/record.url?scp=84977589922&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84977589922&partnerID=8YFLogxK

U2 - 10.1002/jbm.b.33727

DO - 10.1002/jbm.b.33727

M3 - Article

C2 - 27283081

AN - SCOPUS:84977589922

VL - 105

SP - 1916

EP - 1923

JO - Journal of Biomedical Materials Research - Part B Applied Biomaterials

JF - Journal of Biomedical Materials Research - Part B Applied Biomaterials

SN - 1552-4973

IS - 7

ER -